Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Once-weekly Subcutaneous and Once-daily Oral NNC0487-0111 in Participants With Type 2 Diabetes - a Dose Finding Study

NCT06542874 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT06542874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06542874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Once-weekly Subcutaneous and Once-daily Oral NNC0487-0111 in Participants With Type 2 Diabetes - a Dose Finding Study
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Completed
Start date
August 7, 2024
Completion date
October 24, 2025
Enrollment
448 (actual)
Sites
137

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes (t2d)